David Hicks, MD
Foot and Ankle Surgery · Springfield, MONPI 1104807924
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Titan Surgical Group, LLC at 54.3% of the total. Reporting peaked in 2022 at $17,865 and has fallen 91.8% since, to $1,466 in 2025.
Across 112 payments — averaging $197.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$12K
- Arthrex$7K
- Stryker$2K
- Smith+Nephew$326
- Encore Medical, LP$170
- Anika Therapeutics, Inc.$156
- plus $401 from 8 others
What the payments were for
- Travel & lodging$7,44834%
- Food & beverage$2,67712%
- Education$12,00054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 35 | $12,003 |
| Arthrex | 37 | $7,176 |
| Stryker | 10 | $1,892 |
| Smith+Nephew | 17 | $326 |
| Encore Medical, LP | 2 | $170 |
| Anika Therapeutics, Inc. | 1 | $156 |
| Trilliant Surgical LLC. | 1 | $96 |
| Biocomposites Inc | 1 | $80 |
| Innovation Technologies Inc | 1 | $79 |
| Vertex | 3 | $59 |
| Medtronic | 1 | $30 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Orthalign Inc | 1 | $18 |
| Vericel Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,754
- TACTOSET$156
- DJO Surgical AltiVate Reverse$137
How this compares
$22,125 in reported general payments places this provider in the 80th percentile of 163 foot and ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 116 | $1,294 |
| Celecoxib | 41 | $1,138 |
| Oxycodone Hcl | 20 | $188 |
| Cephalexin | 60 | $181 |
| Clindamycin Hcl | 17 | $61 |
| Dexamethasone | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Springfield
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.